Tranding
Hap2py Launches in Thailand, Uniting Profit with Purpose
Abracon Names Brian Holt Vice President of Global Sales
Possibilities and Opportunities: Seminar held in Hong Kong about ETF Connect in China Allocation
enreap becomes an official Atlassian Specialized Partner in ITSM
China's Miao embroidery dresses shine at Milan Fashion Week
2024-11-19 20:24:25

CUSMail

Biotechnology

Qilu Pharmaceutical and Peptron Sign License Agreement for anti-MUC1 ADC
Corporate/ 2023-07-23
Qilu Pharmaceutical and Peptron Sign Lic...

SEOUL,South Korea and JINAN,China,April 16,2021-- Peptron,Inc. ("Peptron",KOSDAQ: 087010),a South Korea-based biotech company,and ...

Transcenta Announced Successful First Patient Dosed in Phase I Clinical Study of TST001 Combined with CAPOX for the Treatment of Patients with First-line Locally Advanced Unresectable or Metastatic Gastric Cancer
Health/ 2023-07-22
Transcenta Announced Successful First Pa...

SUZHOU,China,April 19,2021-- Transcenta Holding Limited (Transcenta),aclinical stageglobal biotherapeutics company with fully-integrated cap...

Health / 2023-07-22
Molecular Matrix and GenScript Partner to Launch...
Corporate / 2023-07-23
WuXi Biologics Receives 2021 Asia-Pacific Biopro...
Health / 2023-07-22
ILC Dover Defines the Future of Sterile Manufact...
Health / 2023-07-22
Moleac Announces US FDA Approval of IND Applicat...
Health / 2023-07-22
GeneLeap Presents New Preclinical Data for Hydro...
Corporate / 2023-07-23
BioVaxys Announces Final Clinical trial results ...
Corporate / 2023-07-23
Kintor Pharmaceutical and Visum Announced Strate...
Health / 2023-07-22
Adlai Nortye Announces First Patient Dosed in Gl...
Health / 2023-07-22
Airway Therapeutics Announces FDA Acceptance of ...
Corporate / 2023-07-23
GenScript, Parkway Laboratories and Diagnostics ...
Health / 2023-07-22
OOOPDS - a surgical planning software received T...
Corporate / 2023-07-23
PharmAbcine presents the non-clinical data of PM...
Corporate / 2023-07-23
Terumo is building a Global Therapeutic Interven...
Corporate / 2023-07-23
Seegene begins exporting its latest COVID-19 var...
Corporate / 2023-07-23
Island Pharmaceuticals Limited to list on the AS...
Corporate / 2023-07-23
Innovent and Lilly Release Phase 3 Results of TY...
Corporate / 2023-07-23
Alphamab Oncology Presented Clinical Data of KN0...
Corporate / 2023-07-23
Ascentage Pharma Releases Preclinical Data of It...

Follow Us

12,345 Fans 12,345 Followers
12,345 Connects 12,345 Followers
12,345 Subscribers 12,345 Followers

Newsletter

Join us to get the latest news.

Received instesting content ASAP

Tranding

News / 2023-11-05
Hap2py Launches in Thailand, Uniting Profit with Purpose
News / 2023-11-05
Abracon Names Brian Holt Vice President of Global Sales
News / 2023-11-05
Possibilities and Opportunities: Seminar held in Hong Ko
News / 2023-11-05
enreap becomes an official Atlassian Specialized Partner
Exhibition / 2023-09-26
China's Miao embroidery dresses shine at Milan Fash

Tags

Computer/ElectronicsBanking/Financial ServiceHealth Care/HospitalTelecommunicationsComputer SoftwareMedical/PharmaceuticalsEntertainmentRetailTransportationEnvironmental Products & Services

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

Categories

NewsBusinessGeneral BusinessFinancial ServicesExhibitionReal Estate and FurnitureAdvertising, Marketing MediaPolicy & Public InterestTechnologyAuto & TransportationBusiness TechnologyConsumer TechnologyEnergyEnvironmentTelecommunicationsHeavy Industry & ManufacturingCorporateEntertainmentLifeStyleTravelFoodsHealthSportsEducation

Tags

Fitness/WellnessArtificial IntelligenceSupply Chain/LogisticsGeneral ManufacturingCloud Computing / Internet of ThingsEnvironmentVoIPMutual FundsCannabisInfectious Disease ControlOTC/SmallCap IRWPublic InterestTobaccoBridal ServicesLegal Services

Quick Links

AboutAdvertisePrivacy & policyTerms & conditionsContact

© CUSMAIL. All Rights Reserved. Operate by Paid Release